Easily Shift From Traditional MedTech Product Design to Modeling and Simulation

Logo
Presented by

Karl D'Souza; Thomas Jansen

About this talk

Current MedTech product development methods are falling short of meeting the rising demand for rapid therapeutic solutions that are safe, effective and withstand stringent regulatory scrutiny. During the past decade, the FDA has been exploring and advocating for the increased use of Computational Modeling & Simulation (CM&S). However, there have also been obstacles in leveraging CM&S to its fullest potential. Beyond the agency’s ongoing development of CM&S regulatory review processes, medical device manufacturers face their own roadblocks in adopting CM&S technology due to legacy processes, vendor selection, and implementation decisions. Unified Modeling and Simulation (MODSIM) from Dassault Systèmes is providing a new paradigm for improving collaboration, process efficiencies and left shifting the value of simulation into the design process. In this presentation, learn how to easily implement a virtual (in silico) MODSIM approach to better manage the conflicting needs for usability, engineering, manufacturability, and cost.
Related topics:

More from this channel

Upcoming talks (0)
On-demand talks (11)
Subscribers (378)
Dassault Systèmes is a science-based company providing technology solutions for innovation. We draw on various branches of science – mathematics, biology, chemistry, physics, geology – to break down silos of knowledge and find the most innovative, sustainable solutions for the future. Subscribe to this channel featuring content for those who develop and bring BioPharma and Medical Device therapies to market for the advancement of human health.